Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 252 of 268 entries
Sorted by: Best Match Show Resources per page
AJH Peer Review 2017.

American journal of hypertension

[No authors listed]
PMID: 30321283
Am J Hypertens. 2018 Oct 15;31(11):1244-1246. doi: 10.1093/ajh/hpy146.

No abstract available.

Cite
AJH Peer Review 2017. Am J Hypertens. 2018;31(11):1244-1246doi: 10.1093/ajh/hpy146.
(2018). AJH Peer Review 2017. American journal of hypertension, 31(11), 1244-1246. https://doi.org/10.1093/ajh/hpy146
"AJH Peer Review 2017." American journal of hypertension vol. 31,11 (2018): 1244-1246. doi: https://doi.org/10.1093/ajh/hpy146
AJH Peer Review 2017. Am J Hypertens. 2018 Oct 15;31(11):1244-1246. doi: 10.1093/ajh/hpy146. PMID: 30321283.
Copy Download .nbib Format: NLM
Effects of Antihypertensive De-prescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results from TONE.

American journal of hypertension

Juraschek SP, Cluett JL, Belanger MJ, Anderson TS, Ishak A, Sahni S, Millar C, Appel LJ, Miller Iii ER, Lipsitz LA, Mukamal KJ.
PMID: 34718403
Am J Hypertens. 2021 Oct 29; doi: 10.1093/ajh/hpab171. Epub 2021 Oct 29.

BACKGROUND: The Trial of Nonpharmacologic Interventions in the Elderly (TONE) demonstrated the efficacy of weight loss and sodium reduction to reduce hypertension medication use in older adults. However, the longer-term effects of drug withdrawal (DW) on blood pressure (BP),...

Cite
Juraschek SP, Cluett JL, Belanger MJ, et al. Effects of Antihypertensive De-prescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results from TONE. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab171.
Juraschek, S. P., Cluett, J. L., Belanger, M. J., Anderson, T. S., Ishak, A., Sahni, S., Millar, C., Appel, L. J., Miller Iii, E. R., Lipsitz, L. A., & Mukamal, K. J. (2021). Effects of Antihypertensive De-prescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results from TONE. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab171
Juraschek, Stephen P, et al. "Effects of Antihypertensive De-prescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results from TONE." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab171
Juraschek SP, Cluett JL, Belanger MJ, Anderson TS, Ishak A, Sahni S, Millar C, Appel LJ, Miller Iii ER, Lipsitz LA, Mukamal KJ. Effects of Antihypertensive De-prescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results from TONE. Am J Hypertens. 2021 Oct 29; doi: 10.1093/ajh/hpab171. Epub 2021 Oct 29. PMID: 34718403.
Copy Download .nbib Format: NLM
Differences in Hypertension Prevalence and Hypertension Control by Urbanization Among Adults in the United States, 2013-2018.

American journal of hypertension

Ostchega Y, Hughes JP, Zhang G, Nwankwo T, Graber J, Nguyen DT.
PMID: 33909014
Am J Hypertens. 2022 Jan 05;35(1):31-41. doi: 10.1093/ajh/hpab067.

BACKGROUND: To examine the associations between urbanization and hypertension, stage II hypertension, and hypertension control.METHODS: Data on 16,360 US adults aged 18 years or older from the 2013-2018 National Health and Nutrition Examination Survey (NHANES) were used to estimate...

Cite
Ostchega Y, Hughes JP, Zhang G, et al. Differences in Hypertension Prevalence and Hypertension Control by Urbanization Among Adults in the United States, 2013-2018. Am J Hypertens. 2022;35(1):31-41doi: 10.1093/ajh/hpab067.
Ostchega, Y., Hughes, J. P., Zhang, G., Nwankwo, T., Graber, J., & Nguyen, D. T. (2022). Differences in Hypertension Prevalence and Hypertension Control by Urbanization Among Adults in the United States, 2013-2018. American journal of hypertension, 35(1), 31-41. https://doi.org/10.1093/ajh/hpab067
Ostchega, Yechiam, et al. "Differences in Hypertension Prevalence and Hypertension Control by Urbanization Among Adults in the United States, 2013-2018." American journal of hypertension vol. 35,1 (2022): 31-41. doi: https://doi.org/10.1093/ajh/hpab067
Ostchega Y, Hughes JP, Zhang G, Nwankwo T, Graber J, Nguyen DT. Differences in Hypertension Prevalence and Hypertension Control by Urbanization Among Adults in the United States, 2013-2018. Am J Hypertens. 2022 Jan 05;35(1):31-41. doi: 10.1093/ajh/hpab067. PMID: 33909014.
Copy Download .nbib Format: NLM
Community Hypertension Screening and Care Referral With Blood Pressure-Measuring Kiosks, Digital Education Modalities, and Text Messages.

American journal of hypertension

Hines AL, Plante TB.
PMID: 34599802
Am J Hypertens. 2022 Jan 05;35(1):19-21. doi: 10.1093/ajh/hpab157.

No abstract available.

Cite
Hines AL, Plante TB. Community Hypertension Screening and Care Referral With Blood Pressure-Measuring Kiosks, Digital Education Modalities, and Text Messages. Am J Hypertens. 2022;35(1):19-21doi: 10.1093/ajh/hpab157.
Hines, A. L., & Plante, T. B. (2022). Community Hypertension Screening and Care Referral With Blood Pressure-Measuring Kiosks, Digital Education Modalities, and Text Messages. American journal of hypertension, 35(1), 19-21. https://doi.org/10.1093/ajh/hpab157
Hines, Anika L, and Plante, Timothy B. "Community Hypertension Screening and Care Referral With Blood Pressure-Measuring Kiosks, Digital Education Modalities, and Text Messages." American journal of hypertension vol. 35,1 (2022): 19-21. doi: https://doi.org/10.1093/ajh/hpab157
Hines AL, Plante TB. Community Hypertension Screening and Care Referral With Blood Pressure-Measuring Kiosks, Digital Education Modalities, and Text Messages. Am J Hypertens. 2022 Jan 05;35(1):19-21. doi: 10.1093/ajh/hpab157. PMID: 34599802; PMCID: PMC8730495.
Copy Download .nbib Format: NLM
Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms.

American journal of hypertension

Bock JM, Vungarala S, Covassin N, Somers VK.
PMID: 34536276
Am J Hypertens. 2022 Jan 05;35(1):3-11. doi: 10.1093/ajh/hpab146.

While the contribution of several physiological systems to arterial blood pressure regulation has been studied extensively, the role of normal and disrupted sleep as a modifiable determinant of blood pressure control, and in the pathophysiology of hypertension, has only...

Cite
Bock JM, Vungarala S, Covassin N, et al. Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms. Am J Hypertens. 2022;35(1):3-11doi: 10.1093/ajh/hpab146.
Bock, J. M., Vungarala, S., Covassin, N., & Somers, V. K. (2022). Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms. American journal of hypertension, 35(1), 3-11. https://doi.org/10.1093/ajh/hpab146
Bock, Joshua M, et al. "Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms." American journal of hypertension vol. 35,1 (2022): 3-11. doi: https://doi.org/10.1093/ajh/hpab146
Bock JM, Vungarala S, Covassin N, Somers VK. Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms. Am J Hypertens. 2022 Jan 05;35(1):3-11. doi: 10.1093/ajh/hpab146. PMID: 34536276; PMCID: PMC8730491.
Copy Download .nbib Format: NLM
Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA).

American journal of hypertension

Akbar A, Liu K, Michos ED, Bancks MP, Brubaker L, Markossian T, Durazo-Arvizu R, Kramer H.
PMID: 33899909
Am J Hypertens. 2022 Jan 05;35(1):22-30. doi: 10.1093/ajh/hpaa186.

BACKGROUND: The sudden urge to urinate, also known as overactive bladder (OAB), may reflect higher sympathetic activity and associate with higher blood pressure (BP).METHODS: This cross-sectional analysis utilized data from sixth follow-up exam (2015-2016) of Multi-Ethnic Study of Atherosclerosis...

Cite
Akbar A, Liu K, Michos ED, et al. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2022;35(1):22-30doi: 10.1093/ajh/hpaa186.
Akbar, A., Liu, K., Michos, E. D., Bancks, M. P., Brubaker, L., Markossian, T., Durazo-Arvizu, R., & Kramer, H. (2022). Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). American journal of hypertension, 35(1), 22-30. https://doi.org/10.1093/ajh/hpaa186
Akbar, Aelia, et al. "Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA)." American journal of hypertension vol. 35,1 (2022): 22-30. doi: https://doi.org/10.1093/ajh/hpaa186
Akbar A, Liu K, Michos ED, Bancks MP, Brubaker L, Markossian T, Durazo-Arvizu R, Kramer H. Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2022 Jan 05;35(1):22-30. doi: 10.1093/ajh/hpaa186. PMID: 33899909; PMCID: PMC8730485.
Copy Download .nbib Format: NLM
From the Editor-in-Chief: Issue at a Glance.

American journal of hypertension

Schiffrin EL.
PMID: 33705538
Am J Hypertens. 2021 Mar 11;34(2):123-124. doi: 10.1093/ajh/hpab030.

No abstract available.

Cite
Schiffrin EL. From the Editor-in-Chief: Issue at a Glance. Am J Hypertens. 2021;34(2):123-124doi: 10.1093/ajh/hpab030.
Schiffrin, E. L. (2021). From the Editor-in-Chief: Issue at a Glance. American journal of hypertension, 34(2), 123-124. https://doi.org/10.1093/ajh/hpab030
Schiffrin, Ernesto L. "From the Editor-in-Chief: Issue at a Glance." American journal of hypertension vol. 34,2 (2021): 123-124. doi: https://doi.org/10.1093/ajh/hpab030
Schiffrin EL. From the Editor-in-Chief: Issue at a Glance. Am J Hypertens. 2021 Mar 11;34(2):123-124. doi: 10.1093/ajh/hpab030. PMID: 33705538.
Copy Download .nbib Format: NLM
Differences in hypertension prevalence and hypertension control by urbanization among adults in the United States, 2013-2018.

American journal of hypertension

Ostchega Y, Hughes JP, Zhang G, Nwankwo T, Graber J, Nguyen DT.
PMID: 33909014
Am J Hypertens. 2021 Apr 28; doi: 10.1093/ajh/hpab067. Epub 2021 Apr 28.

OBJECTIVE: To examine the associations between urbanization and hypertension, stage II hypertension, and hypertension control.METHODS: Data on 16,360 U.S. adults aged 18 years or older from the 2013-2018 National Health and Nutrition Examination Survey (NHANES) were used to estimate...

Cite
Ostchega Y, Hughes JP, Zhang G, et al. Differences in hypertension prevalence and hypertension control by urbanization among adults in the United States, 2013-2018. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab067.
Ostchega, Y., Hughes, J. P., Zhang, G., Nwankwo, T., Graber, J., & Nguyen, D. T. (2021). Differences in hypertension prevalence and hypertension control by urbanization among adults in the United States, 2013-2018. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab067
Ostchega, Yechiam, et al. "Differences in hypertension prevalence and hypertension control by urbanization among adults in the United States, 2013-2018." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab067
Ostchega Y, Hughes JP, Zhang G, Nwankwo T, Graber J, Nguyen DT. Differences in hypertension prevalence and hypertension control by urbanization among adults in the United States, 2013-2018. Am J Hypertens. 2021 Apr 28; doi: 10.1093/ajh/hpab067. Epub 2021 Apr 28. PMID: 33909014.
Copy Download .nbib Format: NLM
Impact of Intravenous Antihypertensives on Outcomes Among Hospitalized Patients.

American journal of hypertension

Bean-Thompson K, Exposito J, Fowler O, Mhaskar R, Chen L, Codolosa JN.
PMID: 33864360
Am J Hypertens. 2021 Aug 09;34(8):867-873. doi: 10.1093/ajh/hpab060.

BACKGROUND: Many hospitalized patients with acute elevations in blood pressure (BP) are treated with intravenous (IV) antihypertensive medications without evidence of benefit. This study investigated the effects of IV as-needed (PRN) antihypertensives on BP, hospital length of stay, and...

Cite
Bean-Thompson K, Exposito J, Fowler O, et al. Impact of Intravenous Antihypertensives on Outcomes Among Hospitalized Patients. Am J Hypertens. 2021;34(8):867-873doi: 10.1093/ajh/hpab060.
Bean-Thompson, K., Exposito, J., Fowler, O., Mhaskar, R., Chen, L., & Codolosa, J. N. (2021). Impact of Intravenous Antihypertensives on Outcomes Among Hospitalized Patients. American journal of hypertension, 34(8), 867-873. https://doi.org/10.1093/ajh/hpab060
Bean-Thompson, Kelsi, et al. "Impact of Intravenous Antihypertensives on Outcomes Among Hospitalized Patients." American journal of hypertension vol. 34,8 (2021): 867-873. doi: https://doi.org/10.1093/ajh/hpab060
Bean-Thompson K, Exposito J, Fowler O, Mhaskar R, Chen L, Codolosa JN. Impact of Intravenous Antihypertensives on Outcomes Among Hospitalized Patients. Am J Hypertens. 2021 Aug 09;34(8):867-873. doi: 10.1093/ajh/hpab060. PMID: 33864360.
Copy Download .nbib Format: NLM
Plasminogen activator inhibitor-1and Adiponectin are associated with metabolic syndrome components.

American journal of hypertension

Vecchiola A, García K, González-Gómez LM, Tapia-Castillo A, Artigas R, Baudrand R, Kalergis AM, Carvajal CA, Fardella CE.
PMID: 34525175
Am J Hypertens. 2021 Sep 15; doi: 10.1093/ajh/hpab138. Epub 2021 Sep 15.

BACKGROUND: We aimed to study the associations of adipocytokines, endothelial damage markers, and hs-CRP with metabolic syndrome (MetS) components.METHODS: This cross-sectional study included 202 subjects categorized into MetS and No-MetS according to Harmonizing ATP III.RESULTS: Subjects with MetS showed...

Cite
Vecchiola A, García K, González-Gómez LM, et al. Plasminogen activator inhibitor-1and Adiponectin are associated with metabolic syndrome components. Am J Hypertens. 2021;doi: 10.1093/ajh/hpab138.
Vecchiola, A., García, K., González-Gómez, L. M., Tapia-Castillo, A., Artigas, R., Baudrand, R., Kalergis, A. M., Carvajal, C. A., & Fardella, C. E. (2021). Plasminogen activator inhibitor-1and Adiponectin are associated with metabolic syndrome components. American journal of hypertension, . https://doi.org/10.1093/ajh/hpab138
Vecchiola, Andrea, et al. "Plasminogen activator inhibitor-1and Adiponectin are associated with metabolic syndrome components." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab138
Vecchiola A, García K, González-Gómez LM, Tapia-Castillo A, Artigas R, Baudrand R, Kalergis AM, Carvajal CA, Fardella CE. Plasminogen activator inhibitor-1and Adiponectin are associated with metabolic syndrome components. Am J Hypertens. 2021 Sep 15; doi: 10.1093/ajh/hpab138. Epub 2021 Sep 15. PMID: 34525175.
Copy Download .nbib Format: NLM
Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT).

American journal of hypertension

Glasser SP, Vitolins M, Rocco MV, Harmon Still C, Cofield SS, Haley WE, Goff D.
PMID: 34528669
Am J Hypertens. 2021 Sep 16; doi: 10.1093/ajh/hpab145. Epub 2021 Sep 16.

BACKGROUND: Adherence to study medications is crucial to evaluating treatment effects in clinical trials.OBJECTIVE: To assess whether in the SPRINT Trial, adherence and cardiovascular outcomes are associated regardless of intervention assignment.METHODS: This study included 9361 participants aged ≥ 50...

Cite
Glasser SP, Vitolins M, Rocco MV, et al. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2021;doi: 10.1093/ajh/hpab145.
Glasser, S. P., Vitolins, M., Rocco, M. V., Harmon Still, C., Cofield, S. S., Haley, W. E., Goff, D. (2021). Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). American journal of hypertension, . https://doi.org/10.1093/ajh/hpab145
Glasser, Stephen P, et al. "Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT)." American journal of hypertension vol. (2021). doi: https://doi.org/10.1093/ajh/hpab145
Glasser SP, Vitolins M, Rocco MV, Harmon Still C, Cofield SS, Haley WE, Goff D. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2021 Sep 16; doi: 10.1093/ajh/hpab145. Epub 2021 Sep 16. PMID: 34528669.
Copy Download .nbib Format: NLM
Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular Hypertrophy.

American journal of hypertension

Guzik BM, McCallum L, Zmudka K, Guzik TJ, Dominiczak AF, Padmanabhan S.
PMID: 33950188
Am J Hypertens. 2021 Jun 22;34(6):636-644. doi: 10.1093/ajh/hpaa194.

BACKGROUND: Left ventricular hypertrophy (LVH) is a well-known target organ damage. Concentric hypertrophy is the strongest predictor of increased risk of cardiovascular events, but the predictive value of individual echocardiographic parameters remains unclear.The aim of this study was to...

Cite
Guzik BM, McCallum L, Zmudka K, et al. Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular Hypertrophy. Am J Hypertens. 2021;34(6):636-644doi: 10.1093/ajh/hpaa194.
Guzik, B. M., McCallum, L., Zmudka, K., Guzik, T. J., Dominiczak, A. F., & Padmanabhan, S. (2021). Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular Hypertrophy. American journal of hypertension, 34(6), 636-644. https://doi.org/10.1093/ajh/hpaa194
Guzik, Bartlomiej M, et al. "Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular Hypertrophy." American journal of hypertension vol. 34,6 (2021): 636-644. doi: https://doi.org/10.1093/ajh/hpaa194
Guzik BM, McCallum L, Zmudka K, Guzik TJ, Dominiczak AF, Padmanabhan S. Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular Hypertrophy. Am J Hypertens. 2021 Jun 22;34(6):636-644. doi: 10.1093/ajh/hpaa194. PMID: 33950188.
Copy Download .nbib Format: NLM
Showing 241 to 252 of 268 entries